FMC Corp vs Herbalife Nutrition Ltd — how do they compare? FMC Corp trades at $8.38 (market cap $1.39B), while Herbalife Nutrition Ltd trades at $12.84 (market cap $1.34B). The key difference: FMC Corp and Herbalife Nutrition Ltd are close in size by market cap, and FMC Corp pays a 3.59% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Herbalife Nutrition Ltd for 43 Days on average.
| FMC | HLF | |
|---|---|---|
Market Cap | $1.39B | $1.34B |
Volume | 4,145,979 | 1,589,457 |
Sector | Basic Materials | Consumer Staples |
52-Week High | $30.63 | $19.96 |
52-Week Low | $8.44 | $7.75 |
Typical Hold Time | 68 Days | 43 Days |
Enterprise Value | $5.19B | $3.18B |
Dividend Yield | 3.59% | — |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (NYSE: FMC) trades at $8.695, down 4.35% today, reflecting ongoing challenges in the agricultural chemicals sector. The stock shows bearish technical signals with mixed earnings performance - beating Q1 and Q2 2026 estimates but missing Q4 2025. Fundamentally, the company faces significant headwinds with a net income margin of -84.83% and negative ROE of -91.47%, though valuation metrics like P/S of 0.34 and P/B of 0.85 suggest potential undervaluation. Recent developments include regulatory submissions for new herbicides in Brazil and a minority equity investment from Tessenderlo Group.
The investment outlook remains cautious despite analyst consensus pointing to 68% upside potential with a $14.60 price target. While aggressive deleveraging efforts and new product pipelines offer potential catalysts, substantial earnings losses, volatile cash flows, and high debt levels present significant risks. The agricultural sector's cyclical nature and pricing pressures require careful monitoring of the company's turnaround execution and market conditions.
HLF trades at $12.65, up 0.56% today, with a bullish technical signal from moving averages. The stock shows attractive valuation with a P/E of 8.22 and P/S of 0.26. Recent earnings were mixed, with a Q1 2026 beat but Q4 2025 and Q2 2026 misses. The company announced a $250 million share repurchase program and a CEO transition effective October 31, 2026. Cash flow trends show improvement, with 2026 projected net cash flow turning positive at $50 million.
The outlook is cautiously optimistic, supported by analyst consensus price target of $19.00 implying significant upside. Key opportunities include debt reduction progress and margin expansion plans. Risks include inconsistent earnings performance, high debt levels, and investor scrutiny following the CEO transition. The stock remains a value play if execution improves.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →